Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stem Cell Authority is a clinical-stage biopharmaceutical company and medical service provider headquartered in Fairlawn, Ohio. Founded in 2001, the company specializes in the collection and cryogenic preservation of hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from Wharton's jelly. In addition to its biobanking operations, Stem Cell Authority develops therapeutic programs for immune system diseases utilizing both small molecules and stem cell technologies. The company also offers regenerative medicine solutions for orthopedic conditions, including stem cell treatments for chronic pain and arthritis affecting the hips, knees, and elbows. Stem Cell Authority is a publicly traded entity on the OTC market under the ticker symbol SCAL.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stem Cell Authority.